Quantitative aerobiologic analysis of an influenza human challenge‐transmission trial. (15th June 2020)

• Record Type: Journal Article
• Authors: Bueno de Mesquita, Paul Jacob; Noakes, Catherine J.; Milton, Donald K.
• Is Part Of: Indoor air. Volume 30:Number 6(2020)
• Page Start: 1189
• Page End: 1198
• Publication Date: 2020-06-15
• Subjects: aerosols -- airborne infection -- Influenza virus -- rebreathed air -- risk assessment -- transmission; Indoor air pollution -- Periodicals; Sick building syndrome -- Periodicals; Ventilation -- Periodicals; 613.5
• DOI: 10.1111/ina.12701
• Languages: English
• ISSNs: 0905-6947

Abstract

Abstract: Despite evidence that airborne transmission contributes to influenza epidemics, limited knowledge of the infectiousness of human influenza cases hinders pandemic preparedness. We used airborne viral source strength and indoor CO2 monitoring from the largest human influenza challenge‐transmission trial (EMIT: Evaluating Modes of Influenza Transmission, ClinicalTrials.gov number NCT01710111) to compute an airborne infectious dose generation rate q = 0.11 (95% CI 0.088, 0.12)/h and calculate the quantity of airborne virus per infectious dose σ = 1.4E + 5 RNA copies/quantum (95% CI 9.9E + 4, 1.8E + 5). We then compared these calculated values to available data on influenza airborne infectious dose from several previous studies, and applied the values to dormitory room environments to predict probability of transmission between roommates. Transmission risk from typical, moderately to severely symptomatic influenza cases is dramatically decreased by exposure reduction via increasing indoor air ventilation. The minority of cases who shed the most virus (ie, supershedders) may pose great risk even in well‐ventilated spaces. Our modeling method and estimated infectiousness provide a ground work for (a) epidemiologic studies of transmission in non‐experimental settings and (b) evaluation of the extent to which airborne exposure control strategies could limit transmission risk.